InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by PARKHILL KAREN L, Chief Financial Officer. Officer active across 1 companies, notably Medtronic plc. Cumulatively, 11 disclosures have been recorded. Total volume traded: €192k. The latest transaction was disclosed on 18 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations11 total
€67,589682 shares@ €99.10340.0001% mcap4.0% of flow
Ordinary Shares
SEC:0001127602-22-010109:0·
049,859 shares0
Ordinary Shares
SEC:0001127602-21-030500·
049,859 shares0
Ordinary Shares
SEC:0001127602-21-030500:0·
037,859 shares0
Ordinary Shares
SEC:0001127602-21-027091·
037,859 shares0
Ordinary Shares
SEC:0001127602-21-027091:0·
€756,2576,839 shares@ €110.58010.0008% mcap92.4% of flow
Ordinary Shares
SEC:0001127602-21-023104·
€756,2576,839 shares@ €110.58010.0008% mcap44.4% of flow
Ordinary Shares
SEC:0001127602-21-023104:0·
0238 shares0
Ordinary Shares
SEC:0001127602-21-020754·
0238 shares0
Ordinary Shares
SEC:0001127602-21-020754:0·
€62,096605 shares@ €102.6380.0001% mcap7.6% of flow
Ordinary Shares
SEC:0001127602-21-020242·
€62,096605 shares@ €102.6380.0001% mcap3.6% of flow
Ordinary Shares
SEC:0001127602-21-020242:0·
11 of 11 declarations
About PARKHILL KAREN L
Karen L. Parkhill serves as Executive Vice President and Chief Financial Officer at Medtronic plc. She oversees the company's financial operations, ensuring compliance and transparency in financial reporting. Her financial expertise is essential for Medtronic's strategy and growth.
